Document Type
Article
Publication Date
2011
Publisher
University of Maryland School of Law
Language
en-US
Abstract
Billions of dollars have been spent in search of cures for diseases such as cancer, muscular dystrophy, heart disease, diabetes, Alzheimer’s, and Parkinson’s. Medical research has consistently pushed the envelope to find new ways to tackle old problems, yet, the field of embryonic stem cell research, a field that many believe could be the key to providing new and effective treatments, remains relatively underfunded due to concerns over ethical considerations. This is largely because the biggest financial backer of scientific research is the federal government, and its desire to finance embryonic stem cell research has waxed and waned over the years with the changing of administrations and the political climate.
Recommended Citation
Michael Ulrich,
Follow the Leader?: Maryland's Response to the New Federal Stem Cell Guidelines
,
in
14
Journal of Health Care Law & Policy Appendix,
S-89
(2011).
Available at:
https://scholarship.law.bu.edu/faculty_scholarship/1202
